Delisting risk
Aditxt (ADTX)
Develops immune, diagnostic, infectious disease, women's health, and oncology programs.
$0.0069
At close−0.00 (−12.66%)
Something off on this page? Send us feedback.
Next report
Dec 2, 2026
estimated · in 90 days
EPS estimate
−$24,408,000,000.00
Revenue estimate
$1.0M
Fiscal quarter
Q2 FY26
EPSReportedEstimate
Nov '24Apr '25May '25Aug '25Nov '25Feb '26May '26Dec '26
Reported−$252,431.80−$404,088.00−$73.82−$31.36−$5.85−$1.48−$2.06Pending
Estimate−$361,600.00−$2,694,824.00−$301,032.00−$243,176.00−$247,696.00−$6,443,712.00−$2,245,536,000.00−$24,408,000,000.00
Surprise+30.2%+85.0%+100.0%+100.0%+100.0%+100.0%+100.0%—
RevenueReportedEstimate
Nov '24Apr '25May '25Aug '25Nov '25Feb '26May '26Dec '26
Reported$124.0K$300.0K$1.0K$1.0K$748$425.0K$12.2KPending
Estimate$250.0K$136.0K$325.0K$350.0K$375.0K$425.0K$1.0M$1.0M
Surprise−50.4%+120.6%−99.7%−99.7%−99.8%0.0%−98.8%—
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2026 | −$24,408,000,000.00 | — | — |
| Sep 2026 | −$224,553,600,000.00 | — | — |
| May 2026 | −$2,245,536,000.00 | −$2.06 | +100.0% |
| Feb 2026 | −$6,443,712.00 | −$1.48 | +100.0% |
| Nov 2025 | −$247,696.00 | −$5.85 | +100.0% |
| Aug 2025 | −$243,176.00 | −$31.36 | +100.0% |
The latest year is open to everyone — the 28 quarters behind it read with an account. Sign in | |||
| May 2025 | |||
| Apr 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Apr 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Apr 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| Mar 2020 | — | — | — |
| Dec 2019 | — | — | — |
| Sep 2019 | — | — | — |
| Jun 2019 | — | — | — |
| Mar 2019 | — | — | — |
| Dec 2018 | — | — | — |
| Sep 2018 | — | — | — |
| Dec 2017 | — | — | — |
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2, 2026 | −$24,408,000,000.00 | — | — | $1.0M | — | — | — |
| Sep 2, 2026 | −$224,553,600,000.00 | — | — | $1.0M | — | — | — |
| May 20, 2026 | −$2,245,536,000.00 | −$2.06 | +100.0% | $1.0M | $12.2K | −98.8% | −12.9% |
| Feb 25, 2026 | −$6,443,712.00 | −$1.48 | +100.0% | $425.0K | $425.0K | 0.0% | −5.2% |
| Nov 17, 2025 | −$247,696.00 | −$5.85 | +100.0% | $375.0K | $748 | −99.8% | −3.8% |
| Aug 14, 2025 | −$243,176.00 | −$31.36 | +100.0% | $350.0K | $1.0K | −99.7% | −1.0% |
The latest year is open to everyone — the 28 quarters behind it read with an account. Sign in | |||||||
| May 15, 2025 | |||||||
| Apr 14, 2025 | |||||||
| Nov 18, 2024 | |||||||
| Aug 19, 2024 | |||||||
| May 20, 2024 | |||||||
| Apr 2, 2024 | |||||||
| Nov 14, 2023 | |||||||
| Aug 14, 2023 | |||||||
| May 15, 2023 | |||||||
| Apr 17, 2023 | |||||||
| Nov 14, 2022 | |||||||
| Aug 15, 2022 | |||||||
| May 16, 2022 | |||||||
| Mar 31, 2022 | |||||||
| Nov 15, 2021 | |||||||
| Aug 12, 2021 | |||||||
| May 12, 2021 | |||||||
| Mar 25, 2021 | |||||||
| Nov 13, 2020 | |||||||
| Aug 13, 2020 | |||||||
| Mar 31, 2020 | — | — | — | — | — | — | — |
| Dec 31, 2019 | — | — | — | — | — | — | — |
| Sep 30, 2019 | — | — | — | — | — | — | — |
| Jun 30, 2019 | — | — | — | — | — | — | — |
| Mar 31, 2019 | — | — | — | — | — | — | — |
| Dec 31, 2018 | — | — | — | — | — | — | — |
| Sep 30, 2018 | — | — | — | — | — | — | — |
| Dec 31, 2017 | — | — | — | — | — | — | — |